Drug hope for people with chronic cough
Up to 10% of adults worldwide experience symptoms with no clear underlying cause.
Some suffer for decades and there is currently no effective treatment.
Researchers at the University of Manchester said a clinical trial resulted in a significant reduction in patients’ symptoms.
Experts said the use of a potential new drug, Gefapixant (MK-7264), appeared to result in a notable decrease in symptoms.
A total of 253 men and women from the US and UK who had suffered from a cough – but were otherwise healthy – that had been unresponsive to treatment for an average of 14.5 years were recruited for the 12-week trial.
Tỷ lệ tử vong vì Nipah lên tới 50%: Hàng loạt sân bay châu Á tái kích hoạt lá chắn thời Covid-19
TPHCM tăng cường giám sát tại các cửa khẩu quốc tế để phòng chống bệnh Nipah
Hoa Kỳ kêu gọi công dân rời Iran “ngay lập tức”
They were either given a placebo or Gefapixant twice a day for 84 days but were not told which, and were given doses of either 7.5mg, 20mg or 50mg.
Before the trial, patients reported that they coughed around 24-29 times per hour.
Following 12 weeks of treatment, those being given the drug reported a reduction to, on average, 11 coughs per hour.
Long-lasting coughs can indicate a number of health problems, including chronic obstructive pulmonary disease, which affects millions of people, or even cancer.
Lung cancer claims 35,300 lives a year in the UK according to Cancer Research UK, partly because it is often diagnosed late.
But the main symptom is a chronic cough – although most instances of this will not be due to cancer.
Vũ Quốc Duy M.D.